Since middle of March, schools were close, health campaign in communities and schools were postponed till September.
Data source
Unless otherwise stated, all programmatic and
epidemiological data underlying these dashboards are provided by countries to ESPEN through WHO
reporting processes, including via the PC Joint Application Package. All reasonable precautions have
been taken to verify this information.
Population living in IUs requiring PC: 2,413,183 SAC | 1,892,905 adults 113 IUs in total | 9 IUs high prevalence & 77 IUs moderate prevalence & 27 IUs low prevalence
Population targeted for PC: 1,863,537 SAC | 1,194,665 Adults 80 IUs targeted
Population treated with PC: 2,946,740 SAC | 2,112,166 Adults 75 IUs achieved effective coverage
Drug regimen: PZQ in 34 IUs PZQ+ALB/MBD in 46 IUs
Coverage indicators
Geographic coverage: 80% of IUs requiring PC
Programme coverage: 158% of SAC and 177% of Adults targeted for PC were treated
National coverage: 122% of SAC and 112% of Adults requiring PC in the country were treated
Please click on an Implementation Unit to view the PC coverage/year